• KOLs Community
    • United
    • United States
    • Sonia Hernández‐díaz
    • Sonia Hernández‐Díaz

      Sonia Hernández‐Díaz

      Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA | CAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; ...



      KOL Resume for Sonia Hernández‐Díaz


      Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA

      Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States


      Harvard T.H. Chan School of Public Health, Boston, MA USA


      Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

      Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.


      Department of Epidemiology, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA


      Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA

      Harvard T.H. Chan School of Public Health, Boston, Massachusetts (S.H.).


      From the Division of Pharmacoepidemiology and Pharmacoeconomics (E.P., B.T.B., K.F.H., R.J.D., H.M.), Department of Medicine, and Division of Women's Health and Division of Epilepsy (P.B.P.), Department of Neurology, Brigham and Women's Hospital and Harvard Medical School; Department of Anesthesiology, Critical Care, and Pain Medicine (B.T.B.), Massachusetts General Hospital and Harvard Medical School; and Department of Epidemiology (S.C.M., J.M.C., A.P., S.H.-D.), Harvard T.H. Chan School of Public Health, Boston, MA.

      Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA


      Harvard T.H. Chan School of Public Health, Boston, Massachusetts


      Department of Epidemiology Harvard T. H. Chan School of Public Health Boston MA USA

      Harvard T. H. Chan School of Public Health, Boston, Massachusetts.


      Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.

      Harvard School of Public Health, Boston, Massachusetts



      Sonia Hernández‐Díaz: Influence Statistics

      Sample of concepts for which Sonia Hernández‐Díaz is among the top experts in the world.
      Concept World rank
      sweden pregnancy #1
      pregnancy 2006 #1
      sgas gdm #1
      controlled asthma marketscan #1
      opioid utilization pregnancy #1
      ≥180 supply #1
      gestational age nicua #1
      nonuse 95 #1
      max risk #1
      hcq prescriptions pregnancy #1
      8297 #1
      evaluate medications #1
      antidepressant late #1
      individual patterns trimester #1
      nbdps pooled data #1
      hypoglycemia bradycardia #1
      arv medicaid #1
      nationwide medicaid #1
      diabetes noninsulin antidiabetics #1
      effectiveness antidepressant therapy #1
      concomitant antibiotic risk #1
      pregnancy completed pregnancies #1
      exposure duloxetine #1
      pregnancy hydroxychloroquine #1
      antibiotics enrollment #1
      pregnancy opioids #1
      preeclampsia diagnoses ppv #1
      association ccmv #1
      mothers reductase inhibitors #1
      acid language #1
      livebirth anencephaly #1
      ircep participants therapeutics #1
      3 phone interviews #1
      bias livebirth #1
      unexposed infants #1
      cdm opioid databases #1
      snri tca monotherapy #1
      stimulant preeclampsia #1
      algorithms medicaid #1
      ritonavirboosted lopinavir tdfftclpv #1
      marketscan pregabalin #1
      algorithm elastic net #1
      prenatal treatment outcomes #1
      tdfftclpv risk #1
      preterm infant 95 #1
      methadone addiction severity #1
      birth cohorts birth #1
      opioids psychotropic medications #1
      dcd 7 children #1
      effectiveness pregnant #1


      Prominent publications by Sonia Hernández‐Díaz

      KOL-Index: 22741

      Importance: Prenatal antidepressant exposure has been associated with adverse outcomes. Previous studies, however, may not have adequately accounted for confounding.

      Objective: To evaluate alternative hypotheses for associations between first-trimester antidepressant exposure and birth and neurodevelopmental problems.

      Design, Setting, and Participants: This retrospective cohort study included Swedish offspring born between 1996 and 2012 and followed up through 2013 or censored by death ...

      Known for Gestational Age | Preterm Birth | Maternal Antidepressant | Autism Spectrum | Hyperactivity Disorder
      KOL-Index: 20346

      OBJECTIVE: To determine whether use of serotonin or non-serotonin reuptake inhibitors near to delivery is associated with postpartum hemorrhage.

      DESIGN: Cohort study.

      SETTING: 2000-07 nationwide Medicaid data (Medicaid Analytic eXtract).

      POPULATION: 106,000 pregnant women aged 12-55 with a diagnosis of mood or anxiety disorder. Women were categorized into four mutually exclusive exposure groups according to pharmacy dispensing data: current (delivery date), recent (1-30 days before ...

      Known for Postpartum Hemorrhage | Reuptake Inhibitors | United States | Delivery Risk | Exposure Serotonin
      KOL-Index: 16319

      BACKGROUND: Use of angiotensin-converting-enzyme (ACE) inhibitors during the second and third trimesters of pregnancy is contraindicated because of their association with an increased risk of fetopathy. In contrast, first-trimester use of ACE inhibitors has not been linked to adverse fetal outcomes. We conducted a study to assess the association between exposure to ACE inhibitors during the first trimester of pregnancy only and the risk of congenital malformations.

      METHODS: We studied a ...

      Known for Major Congenital Malformations | Trimester Exposure | Ace Inhibitors | Pregnancy Risk | Congenital Humans Infant
      KOL-Index: 15934

      OBJECTIVE: To investigate whether pre-eclampsia is more common in first pregnancies solely because fewer affected women, who presumably have a higher risk of recurrence, go on to have subsequent pregnancies.

      DESIGN: Prospective cohort study.

      SETTING: Swedish Medical Birth Register.

      PARTICIPANTS: 763 795 primiparous mothers who had their first births in Sweden, 1987-2004.

      MAIN OUTCOME MEASURES: Pre-eclampsia.

      RESULTS: The risk of pre-eclampsia was 4.1% in the first pregnancy and 1.7% in ...

      Known for Subsequent Pregnancies | Eclampsia Pregnancy | Multiparous Women | Prospective Cohort | Recurrence Risk
      KOL-Index: 14203

      Importance: Interpregnancy intervals shorter than 18 months are associated with higher risks of adverse pregnancy outcomes. It is currently unknown whether short intervals are associated with increased risks among older women to the same extent as among younger women.

      Objective: To evaluate whether the association between short interpregnancy (delivery to conception) interval and adverse pregnancy outcomes is modified by maternal age.

      Design, Setting, and Participants: A population-based ...

      Known for Maternal Age | 6 Months | Short Interpregnancy | Pregnancy Outcomes | Preterm Delivery
      KOL-Index: 13378

      BACKGROUND: Multivitamin supplementation in pregnant women may reduce the risks of cardiovascular defects, oral clefts, and urinary tract defects in their infants. We evaluated whether the folic acid component of multivitamins is responsible for the reduction in risk by examining the associations between maternal use of folic acid antagonists and these congenital malformations.

      METHODS: We compared data on exposure to folic acid antagonists that act as dihydrofolate reductase inhibitors ...

      Known for Folic Acid Antagonists | Oral Clefts | Cardiovascular Defects | Infants Mothers | Antiepileptic Drugs
      KOL-Index: 13357

      Objectives To assess the impact of in utero co-exposure to psychotropic medications and opioids on the incidence and severity of neonatal drug withdrawal.Design Observational cohort study.Setting Nationwide sample of pregnancies in publicly insured women in the US, nested in the Medicaid Analytic eXtract (2000-10).Participants 201 275 pregnant women with public insurance who were exposed to opioids around the time of delivery and their liveborn infants.Interventions In utero exposure to ...

      Known for Psychotropic Medications | Utero Exposure Opioids | Drug Withdrawal | Benzodiazepines Gabapentin | Opioid Disorders
      KOL-Index: 12969

      BACKGROUND: Whether the use of selective serotonin-reuptake inhibitors (SSRIs) and other antidepressants during pregnancy is associated with an increased risk of congenital cardiac defects is uncertain. In particular, there are concerns about a possible association between paroxetine use and right ventricular outflow tract obstruction and between sertraline use and ventricular septal defects.

      METHODS: We performed a cohort study nested in the nationwide Medicaid Analytic eXtract for the ...

      Known for Cardiac Defects | Pregnancy Risk | Antidepressants Trimester | Women Depression | Congenital Humans Infant
      KOL-Index: 12926

      A previous study suggested an increased risk of preeclampsia among women treated with selective serotonin reuptake inhibitors (SSRIs). Using population-based health-care utilization databases from British Columbia (1997-2006), the authors conducted a study of 69,448 pregnancies in women with depression. They compared risk of preeclampsia in women using SSRIs, serotonin-norepinephrine reuptake inhibitors (SNRIs), or tricyclic antidepressants (TCAs) between gestational weeks 10 and 20 with ...

      Known for Preeclampsia Women | Elevated Risk | Depression Antidepressants | Agents Tricyclic | Pregnancy Complications
      KOL-Index: 12916

      BACKGROUND: Previous studies have suggested a potential risk of cervical cancer in patients with systemic inflammatory diseases (SID) such as inflammatory bowel disease (IBD) and systemic lupus erythematosus (SLE).

      OBJECTIVES: To assess the risk of high-grade cervical dysplasia, a surrogate endpoint for cervical cancer and cervical cancer, in women with SID, including IBD, psoriasis, rheumatoid arthritis (RA) or SLE, compared with the risk in women without SID.

      METHODS: Using US ...

      Known for Cervical Cancer | Risk Women | Systemic Inflammatory Diseases | Rheumatoid Arthritis | Inflammatory Bowel Disease
      KOL-Index: 12914

      IMPORTANCE: Between 0.3% and 0.5% of all pregnancies occur among women with epilepsy. Evidence suggests an increase in perinatal morbidity and mortality among women with epilepsy. However, these risks have not been quantified in large population-based samples.

      OBJECTIVE: To report on the risk for death and adverse outcomes at the time of delivery for women with epilepsy in the United States.

      DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of pregnant women identified ...

      Known for Women Epilepsy | United States | Delivery Hospitalization | Adverse Outcomes | Risk Death
      KOL-Index: 12826

      Importance: Given the rapidly increasing use of stimulant medications during pregnancy and among women of reproductive age who may become pregnant inadvertently, there is a need to better understand their safety.

      Objective: To examine the risk of congenital malformations associated with intrauterine exposure to stimulants.

      Design, Setting, and Participants: Cohort study of the Medicaid-insured population in the United States nested in the 2000-2013 US Medicaid Analytic eXtract, with ...

      Known for Congenital Malformations | United States | Pregnancy Risk | Reproductive Age | Newborn Methylphenidate
      KOL-Index: 12696

      BACKGROUND: Nausea and vomiting of pregnancy (NVP) occurs in up to 80% of pregnant women, but its association with birth outcomes is not clear. Several medications are used for the treatment of NVP; however, data are limited on their possible associations with birth defects.

      METHODS: Using data from the National Birth Defects Prevention Study (NBDPS)-a multi-site, population-based, case-control study-we examined whether NVP or its treatment was associated with the most common noncardiac ...

      Known for Birth Defects | Pregnancy Nvp | Nausea Vomiting | Aor 95 | Cleft Palate
      KOL-Index: 12502

      BACKGROUND: Estrogen plus progestin therapy increases the risk for coronary heart disease (CHD) in postmenopausal women. However, this increased risk might be limited to the first years of use and to women who start therapy late in menopause.

      OBJECTIVE: To estimate the effect of continuous estrogen plus progestin therapy on CHD risk over time and stratified by years since menopause.

      DESIGN: Women's Health Initiative randomized, double-blinded, placebo-controlled trial. ...

      Known for Coronary Heart Disease | Progestin Therapy | Menopause Women | Chd Risk | 2 Years
      KOL-Index: 12475

      BACKGROUND: The risk of birth defects after antenatal exposure to selective serotonin-reuptake inhibitors (SSRIs) remains controversial.

      METHODS: We assessed associations between first-trimester maternal use of SSRIs and the risk of birth defects among 9849 infants with and 5860 infants without birth defects participating in the Slone Epidemiology Center Birth Defects Study.

      RESULTS: In analyses of defects previously associated with SSRI use (involving 42 comparisons), overall use of ...

      Known for Birth Defects | Ssris Risk | Selective Serotonin | Uptake Inhibitors | Paroxetine Sertraline

      Key People For United States

      Top KOLs in the world
      Ahmedin M Jemal
      united states breast cancer addis ababa
      Ronald C Kessler
      mental disorders united states major depression
      Katherine M Flegal
      united states prevalence obesity blood lead levels
      Margaret D Carroll
      united states angeles county prevalence obesity
      Walter Churchill Willett
      breast cancer type 2 diabetes coronary heart disease
      Cynthia L Ogden
      united states children adolescents prevalence obesity

      Sonia Hernández‐Díaz:Expert Impact

      Concepts for whichSonia Hernández‐Díazhas direct influence:United states,  Pregnant women,  Birth defects,  Congenital malformations,  Gestational age,  Atypical antipsychotics,  Oral clefts,  Maternal age.

      Sonia Hernández‐Díaz:KOL impact

      Concepts related to the work of other authors for whichfor which Sonia Hernández‐Díaz has influence:Pregnant women,  Folic acid,  Preterm birth,  United states,  Gestational age,  Observational studies,  Selection bias.



      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA | CAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Bos

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.